Tenax Therapeutics Inc (TENX) support and resistance · P/E 3.4, $24.1M cap
Tenax Therapeutics Inc (TENX) is a biotechnology company listed on US.
This page maps Tenax Therapeutics Inc (TENX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TENX revenue for 2026-06-30 was $0. Net income was -$33.5M. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
TENX currently screens at market cap $24.1M and trailing P/E 3.4. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TENX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TENX quote page for the session range and the stock page for the full model.
Not investment advice.